3.24000 USD
0.0774
2.33%
Last update Dec 15, 4:04 PM GMT
Main market
Day range
3.24000
3.31930
Previous close
3.31738
Open
3.27000
Access this stock data via API
Subscribe
Aclaris Therapeutics Inc.
3.24
0.08
2.33%

Financials

Income statement

Fiscal date 2021 2020 2019 2018
Total reported revenue 5.1B 4.6B 4.6B 4.3B
Cost of revenue 209.3M 200.5M 167.9M 158.7M
Gross profit 4.9B 4.4B 4.4B 4.1B
Operating expense
Research & development
Selling general and admin 3.2B 2.9B 2.9B 2.7B
Other operating expenses 685.2M 634.4M 623.6M 585.1M
Operating income 806.5M 647.8M 692.5M 681.6M
Non operating interest income
Income
Expense 164.6M 184.2M 159.7M 147.3M
Other income expense 15.3M 9M 29.5M -41.1M
Pretax income 657.2M 472.6M 562.3M 493.2M
Tax provision 139.6M 103.8M 115.9M 118.9M
Net income 517.2M 368.8M 445.8M 375.4M
Basic EPS 4.2 2.9 3.7 3.0
Diluted EPS 4.1 2.9 3.6 2.9
Basic average shares 99M 98.6M 98M 97.9M
Diluted average shares 99M 98.6M 98M 97.9M
EBITDA 1.1B 904.9M 948.4M 892.2M
Net income from continuing op. 517.2M 368.8M 445.8M 375.4M
Minority interests -105M -84.6M -87.1M -83.1M
Preferred stock dividends 1.8M 1M 1.3M 900K
Access /income_statement data via our API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 6 hours 11 minutes

10:18
00:00
08:00
16:30
23:59

Trading Hours (Monday - Friday):

Pre-market
07:15 - 08:00
Main market
08:00 - 16:30
Post-market
16:30 - 17:15
All times are displayed in the Europe/London timezone (GMT, UTC+00:00).